Search for: "MERRELL"
Results 141 - 160
of 601
Sort by Relevance
|
Sort by Date
2 Feb 2017, 1:22 pm
Below the jump is a compilation of Judge Neil Gorsuch’s jurisprudence on the U.S. [read post]
6 Jan 2017, 6:28 am
Merrell Dow Pharmaceuticals,Inc., 509 U.S. 579 (1993). [read post]
4 Jan 2017, 7:09 pm
Merrell Dow Pharm, Inc., 509 US. 579, 593-94 (1993)). [read post]
2 Dec 2016, 9:35 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
16 Nov 2016, 8:11 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
1 Nov 2016, 8:27 pm
Merrell Dow Pharmaceuticals must be satisfied for a class to be certified under Federal Rule of Civil Procedure 23 when challenged expert testimony is at issue, particularly in light of this court leaving issues open in Tyson Foods, Inc. v. [read post]
31 Oct 2016, 7:18 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the United States Supreme Court replaced the old Frye test for determining the admissibility of expert evidence with the new Daubert, pursuant to which judges serve as gatekeepers and... [read post]
27 Oct 2016, 10:27 am
Merrell Dow Pharmaceuticals, in which the Supreme Court established the standards for the use of expert and scientific evidence in federal courts. [read post]
20 Oct 2016, 1:57 pm
Merrell Dow Pharms. [read post]
14 Oct 2016, 7:56 pm
In yet another law review article on Daubert, Susan Haack has managed mostly to repeat her past mistakes, while adding a few new ones to her exegesis of the law of expert witnesses. [read post]
16 Sep 2016, 2:02 pm
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). [read post]
13 Sep 2016, 4:57 am
Merrell Dow; making it difficult for respondents to obtain exculpatory material; and “arbitrarily and reflexively” denying respondents’ requests to take depositions, which, according to Tilton, have been fruitless under the SEC’s existing rules no matter how compelling the reason except for the unavailability of the deponent (a rule, the complaint points out, which does not apply to a witness for the Division of Enforcement). [read post]
25 Aug 2016, 10:28 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), Rule 702(a1) was not amended. [read post]
25 Aug 2016, 10:28 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), Rule 702(a1) was not amended. [read post]
8 Aug 2016, 12:50 pm
Annsley Merrelle Ward reports on the new guide with a little help from Merpel.* When its comes to "deadwood", leave it in the State of South Dakota and out of Trademark Office policyIs unused "deadwood"really cluttering up trade mark registers? [read post]
5 Aug 2016, 6:36 am
Still, manufacturer Merrell Dow Pharmaceuticals pulled the drug from the market in 1983 because of the backlash of legal and liability issues. [read post]
11 Jul 2016, 4:03 am
Merrel Dow. [read post]
15 Jun 2016, 12:34 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
15 Jun 2016, 12:34 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
1 Jun 2016, 5:35 pm
., 511 U.S. 863, 868, 114 S.Ct. 1992, 1996 (1994) (quoting Richardson–Merrell, Inc. v. [read post]
